The cardiovascular effects of hyperthyroidism.
Nabbout
Lara A
LA
Department of Medicine, The Methodist Hospital, Houston, Texas, USA.
Robbins
Richard J
RJ
D002317:Cardiovascular Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000209:etiology* / Q000266:history / Q000378:metabolism / Q000503:physiopathology; D004104:Diiodothyronines / Q000627:therapeutic use; D006439:Hemodynamics; D049671:History, 18th Century; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications* / Q000188:drug therapy / Q000266:history / Q000378:metabolism / Q000503:physiopathology; D009131:Muscle, Smooth, Vascular / Q000378:metabolism / Q000503:physiopathology; D032383:Myocytes, Cardiac / Q000378:metabolism; D011422:Propionates / Q000627:therapeutic use; D015398:Signal Transduction / Q000187:drug effects; D013963:Thyroid Hormones / Q000378:metabolism*
D002317:Cardiovascular Agents; D004104:Diiodothyronines; D011422:Propionates; D013963:Thyroid Hormones; C082182:3,5-diiodothyropropionic acid